BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31898097)

  • 1. Do Body Mass Index and Breast Density Impact Cancer Risk Among Women with Lobular Carcinoma In Situ?
    Minami CA; Zabor EC; Gilbert E; Newman A; Park A; Jochelson MS; King TA; Pilewskie ML
    Ann Surg Oncol; 2020 Jun; 27(6):1844-1851. PubMed ID: 31898097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
    King TA; Pilewskie M; Muhsen S; Patil S; Mautner SK; Park A; Oskar S; Guerini-Rocco E; Boafo C; Gooch JC; De Brot M; Reis-Filho JS; Morrogh M; Andrade VP; Sakr RA; Morrow M
    J Clin Oncol; 2015 Nov; 33(33):3945-52. PubMed ID: 26371145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
    Wong SM; King T; Boileau JF; Barry WT; Golshan M
    Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for women with lobular carcinoma in situ (LCIS).
    Oppong BA; King TA
    Oncology (Williston Park); 2011 Oct; 25(11):1051-6, 1058. PubMed ID: 22106556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
    Aulmann S; Penzel R; Schirmacher P; Sinn HP
    Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.
    Mullooly M; Khodr ZG; Dallal CM; Nyante SJ; Sherman ME; Falk R; Liao LM; Love J; Brinton LA; Gierach GL
    Am J Epidemiol; 2017 Dec; 186(12):1329-1340. PubMed ID: 28637226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological survey of preinvasive breast cancer.
    Vandenbroucke A; Bourdon C
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():3-10. PubMed ID: 8298449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lobular carcinoma in situ: observation without surgery as an appropriate therapy.
    Carson W; Sanchez-Forgach E; Stomper P; Penetrante R; Tsangaris TN; Edge SB
    Ann Surg Oncol; 1994 Mar; 1(2):141-6. PubMed ID: 7834439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of the Breast Cancer Surveillance Consortium Model Among Women with LCIS.
    Eroglu I; Sevilimedu V; Park A; King TA; Pilewskie ML
    Breast Cancer Res Treat; 2022 Jul; 194(2):257-264. PubMed ID: 35595928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pathologic Finding of Combined Lobular Carcinoma
    Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
    Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ.
    Miller ME; Muhsen S; Zabor EC; Flynn J; Olcese C; Giri D; Van Zee KJ; Pilewskie M
    Ann Surg Oncol; 2019 Dec; 26(13):4317-4325. PubMed ID: 31552614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing incidence of lobular carcinoma in situ of the breast.
    Li CI; Anderson BO; Daling JR; Moe RE
    Breast Cancer Res Treat; 2002 Oct; 75(3):259-68. PubMed ID: 12353815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of contralateral breast cancer among women with carcinoma in situ of the breast.
    Habel LA; Moe RE; Daling JR; Holte S; Rossing MA; Weiss NS
    Ann Surg; 1997 Jan; 225(1):69-75. PubMed ID: 8998122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second cancers following in situ carcinoma of the breast.
    Franceschi S; Levi F; La Vecchia C; Randimbison L; Te VC
    Int J Cancer; 1998 Jul; 77(3):392-5. PubMed ID: 9663601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening breast MR imaging in women with a history of lobular carcinoma in situ.
    Sung JS; Malak SF; Bajaj P; Alis R; Dershaw DD; Morris EA
    Radiology; 2011 Nov; 261(2):414-20. PubMed ID: 21900617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.
    Sasson AR; Fowble B; Hanlon AL; Torosian MH; Freedman G; Boraas M; Sigurdson ER; Hoffman JP; Eisenberg BL; Patchefsky A
    Cancer; 2001 May; 91(10):1862-9. PubMed ID: 11346867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease.
    Page DL; Kidd TE; Dupont WD; Simpson JF; Rogers LW
    Hum Pathol; 1991 Dec; 22(12):1232-9. PubMed ID: 1748429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobular carcinoma in situ (LCIS): pathology and treatment.
    Gump FE
    J Cell Biochem Suppl; 1993; 17G():53-8. PubMed ID: 8007710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.
    Ottesen GL; Graversen HP; Blichert-Toft M; Christensen IJ; Andersen JA
    Breast Cancer Res Treat; 2000 Aug; 62(3):197-210. PubMed ID: 11072784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.